Pages that link to "Q44484211"

The following pages link to Antiviral activity of gyrase inhibitors norfloxacin, coumermycin A1 and nalidixic acid (Q44484211):

Displaying 14 items.

• BK virus-associated hemorrhagic cystitis after pediatric stem cell transplantation (Q26886376) (← links)
• Polyomavirus BK infection in blood and marrow transplant recipients (Q34732733) (← links)
• Viral drug sensitivity testing using quantitative PCR: effect of tyrosine kinase inhibitors on polyomavirus BK replication (Q34786769) (← links)
• Polyoma BK virus and haemorrhagic cystitis in haematopoietic stem cell transplantation: a changing paradigm (Q36267914) (← links)
• Reversible suppression by nalidixic acid of anchorage-independent growth of mouse cells transformed by 3-methylcholanthrene or an activated c-Ha-ras gene (Q36467821) (← links)
• Polyomavirus-associated nephropathy: update of clinical management in kidney transplant patients (Q36492408) (← links)
• Polyomavirus-associated nephropathy: update on antiviral strategies (Q36492418) (← links)
• Antivirals for the treatment of polyomavirus BK replication (Q36723806) (← links)
• Efficacy of levofloxacin in the treatment of BK viremia: a multicenter, double-blinded, randomized, placebo-controlled trial (Q37621540) (← links)
• The human polyomavirus BK (BKPyV): virological background and clinical implications (Q38115582) (← links)
• Fluoroquinolones inhibit human polyomavirus BK (BKV) replication in primary human kidney cells (Q39499064) (← links)
• Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation. (Q45265773) (← links)
• ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients (Q47391256) (← links)
• Fluoroquinolones and BK Virus Nephropathy: A Myth or a Reality (Q59353646) (← links)